164 related articles for article (PubMed ID: 20305419)
1. Subcutaneous metastases of colorectal cancer detected with PET/CT.
Karyagar S; Karyagar SS; Kece C; Ozdil B
Clin Nucl Med; 2010 Apr; 35(4):267-8. PubMed ID: 20305419
[TBL] [Abstract][Full Text] [Related]
2. Synchronous adenocarcinoma of the appendix demonstrated on F-18 FDG PET/CT.
Lu SJ; Osmany S; Khoo JB; Ng DC
Clin Nucl Med; 2010 Apr; 35(4):256-7. PubMed ID: 20305414
[No Abstract] [Full Text] [Related]
3. Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver metastases.
Bienert M; McCook B; Carr BI; Geller DA; Sheetz M; Amesur N; Avril N
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):723. PubMed ID: 15599525
[No Abstract] [Full Text] [Related]
4. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous and muscular metastasis of the colorectal cancer on F-18 FDG PET/CT.
Karyağar S; Kesici U; Karyağar S; Kece C; Güner A; Duman G; Küçütulu U
Turk J Gastroenterol; 2015 Mar; 26(2):195-6. PubMed ID: 25835124
[No Abstract] [Full Text] [Related]
6. Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
Rehani B; Strohmeyer P; Jacobs M; Mantil J
Clin Nucl Med; 2006 Dec; 31(12):812-3. PubMed ID: 17117082
[TBL] [Abstract][Full Text] [Related]
7. Incidental early stage endometrial adenocarcinoma diagnosed by F-18 FDG PET-CT, which was negative on ultrasound and nonspecific on MRI.
Makis W; Abikhzer G; Stern J
Clin Nucl Med; 2010 Apr; 35(4):265-6. PubMed ID: 20305418
[No Abstract] [Full Text] [Related]
8. Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
Kang S; Ahn BC; Hong CM; Song BI; Lee HJ; Jeong SY; Lee SW; Lee J; Lee SJ
Nuklearmedizin; 2011; 50(3):116-21. PubMed ID: 21246162
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis supporting algorithm for lymph node metastases from colorectal carcinoma on 18F-FDG PET/CT.
Inoue K; Sato T; Kitamura H; Ito M; Tsunoda Y; Hirayama A; Kurosawa H; Tanaka T; Fukushi M; Moriyama N; Fujii H
Ann Nucl Med; 2008 Jan; 22(1):41-8. PubMed ID: 18250986
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of a tubercular fistula-in-ano on F-18 FDG PET/CT.
Garg G; Tripathi M; D'Souza M; Jaimini A; Jain N; Khurana A; Sharma R; Mondal A
Clin Nucl Med; 2010 Apr; 35(4):300-2. PubMed ID: 20305432
[No Abstract] [Full Text] [Related]
11. The contribution of ¹⁸F-FDG PET/CT in a patient with cutaneous metastases of squamous cell carcinoma of the penis.
Banzo J; Ubieto MA; Andrés A; Tardín L; Rambalde EF; Cancer LF; Razola P; Prats E
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):293-5. PubMed ID: 24866051
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
Truant S; Huglo D; Hebbar M; Ernst O; Steinling M; Pruvot FR
Br J Surg; 2005 Mar; 92(3):362-9. PubMed ID: 15672427
[TBL] [Abstract][Full Text] [Related]
13. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT.
Dirisamer A; Halpern BS; Flöry D; Wolf F; Beheshti M; Mayerhoefer ME; Langsteger W
Eur J Radiol; 2010 Feb; 73(2):324-8. PubMed ID: 19200683
[TBL] [Abstract][Full Text] [Related]
14. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
15. A case of malignant melanoma with cardiac and gallbladder metastases detected by FDG PET-CT.
Ozülker T; Ozülker F; Cicin I; Ozpaçac T
Clin Nucl Med; 2009 Dec; 34(12):948-9. PubMed ID: 20139846
[No Abstract] [Full Text] [Related]
16. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
17. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
19. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
[TBL] [Abstract][Full Text] [Related]
20. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer.
Kim JH; Czernin J; Allen-Auerbach MS; Halpern BS; Fueger BJ; Hecht JR; Ratib O; Phelps ME; Weber WA
J Nucl Med; 2005 Apr; 46(4):587-95. PubMed ID: 15809480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
